Ainos (AIMD US)

Analysis

Information Technology • United States

Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its smelltech platform, powered by AI Nose and smell language model (SLM), digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Active clinical programs include HIV-related oral warts, primary Sjögren’s syndrome, and feline chronic gingivostomatitis (FCGS). Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age.

Refresh

Exchange Announcement • 28 Sep 2026 20:00

Current Report (Form 8-K | Period ending 2026-09-24)

Exchange Announcement • 04 Aug 2026 05:20

Current Report (Form 8-K | Period ending 2026-08-03)

Exchange Announcement • 03 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 25 Jul 2026 00:16

424B5 | Prospectus

Exchange Announcement • 11 Jul 2026 04:10

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Current Report (Form 8-K | Period ending 2026-09-24)

Current Report (Form 8-K | Period ending 2026-08-03)

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

424B5 | Prospectus

Current Report (Form 8-K | Period ending 2026-07-09)